SCHEMBL5011341

SCHEMBL5011341

CCC1CCCCN1CCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.50
HTR7 P34969 1/20 0.50
HRH1 P35367 1/20 0.50
DRD3 P35462 1/20 0.50
HTR2B P41595 1/20 0.50
ACHE P22303 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAOB P27338 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 3/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
TERT O14746 1/20 0.46
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11196977 0.84 HTR1A (0.53) HTR1AHTR7HRH1DRD3HTR2B
SCHEMBL24684797 0.80 HTR1A (0.51) HTR1AHTR7HRH1DRD3HTR2B
SCHEMBL31326934 0.79 HPGD (0.51) HTR1AHTR7HRH1DRD3HTR2B
SCHEMBL3455464 0.76 NPC1 (0.60) ACHESMN1; SMN2MEN1KMT2ATP53
SCHEMBL3592341 0.75 SMN1; SMN2 (0.52) HTR1AHTR7HRH1DRD3HTR2B
SCHEMBL1569172 0.74 HTR1A (0.69) HTR1ADRD3MAOB
SCHEMBL2149893 0.73 POLB (0.62) POLBALDH1A1
SCHEMBL2149809 0.73
SCHEMBL9016847 0.73 MEN1 (0.56) MEN1KMT2AALDH1A1
SCHEMBL23828673 0.73 S1PR1 (0.46) MEN1KMT2ATERTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008007835-A1 2,4-QUINAZOLINE DERIVATIVES HAVING ACTIVITY TO T-TYPE CALCIUM CHANNEL AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-01-17 WO disclosed
WO-2008007835-A1 2,4-QUINAZOLINE DERIVATIVES HAVING ACTIVITY TO T-TYPE CALCIUM CHANNEL AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-01-17 WO disclosed
EP-1871376-A2 INHIBITORS OF AKT ACTIVITY Merck & Co., Inc. (US) 2008-01-02 EP disclosed
WO-2007011290-A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives RESPIRATORIUS AB (SE) 2007-01-25 WO disclosed
WO-2006110638-A2 INHIBITORS OF AKT ACTIVITY MERCK & CO., INC. (US) 2006-10-19 WO disclosed